Share the post "Shareholding Pattern: Shareholding Pattern Parmax Pharma FY(Q1-Jun 2024-2025)"
Parmax Pharma has released its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q1-Jun 2024-2024).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
|---|---|---|---|---|---|
| Promoters | 0.12 | 0.12 | 30.83 | 30.8 | -0.03 % |
| Public | 0.26 | 0.26 | 69.17 | 69.2 | +0.03 % |
| DII | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters’ shareholding decreased from 30.83% in March 2024 to 30.8% in June 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.The percentage of shares held by the public increased from 69.17% in March 2024 to 69.2% in June 2024.This change suggests that the public’s investment in the company grew during the quarter.
Let’s look into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
| Shareholder Name | Previous Quarter Quantity (In crores) | Current Quarter Quantity (In crores) | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| ALKESH MAHASUKH GOPANI | 0.067 | 0.067 | 17.95 | 17.92 | -0.03 % |
ALKESH MAHASUKH GOPANI faced a downturn in stakeholding this quarter, witnessing a decline of -0.03 % in stakeholding compared to the previous quarter.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.127 | 0.128 | 34.08 | 34.31 | + 0.23 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.117 | 0.118 | 31.26 | 31.47 | + 0.21 % |
| PRADEEP RAMNIKLAL GOSALIA | 0.025 | 0.026 | 6.77 | 6.89 | + 0.12 % |
| Non Resident Indians (NRIs) | 0.001 | 0.001 | 0.25 | 0.21 | -0.04 % |
| Any Other (specify) | 0.003 | 0.002 | 0.86 | 0.49 | -0.37 % |
| HUF | 0.003 | 0.002 | 0.86 | 0.46 | -0.4 % |
| Trusts | 0 | 0.000 | 0 | 0.03 | +0.03% |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.23 %.Leading the way to higher stakeholding, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs has significantly boosted stakeholding by an impressive 0.21 %.Leading the way to higher stakeholding, PRADEEP RAMNIKLAL GOSALIA has significantly boosted stakeholding by an impressive 0.12 %.Observations show a significant difference of -0.04 % in Non Resident Indians (NRIs)’s financial performance between quarters.Observations show a significant difference of -0.37 % in Any Other (specify)’s financial performance between quarters.Observations show a significant difference of -0.4 % in HUF’s financial performance between quarters.Trusts had no shares in the previous quarter but now holds 0.03% of shares in the current quarter.
[my_shortcode1 values=”Parmax Pharma “]
